Annual Report 2017

April 16, 2018

What to Expect from This Document?

Better known up until a few years ago for its bioseparation and enabling of manufacturing of biopharmaceuticals expertise, Prometic has during 2017, continued its transition that has transformed the company into a biopharmaceutical corporation with two drug discovery platforms focusing on rare and orphan diseases representing significant and unmet medical needs.

No Previous Flipbooks

Next Flipbook
Annual Information Form 2017
Annual Information Form 2017

During 2017 Prometic has continued its transition into a biopharmaceutical corporation with two drug discov...